lunedì, 20 marzo 2023

Notizie AIOM – anno XIII n. 564

18 Dicembre 2015

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: The Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study

Background: Patients with metastatic renal carcinoma (mRCC) treated with first-line pazopanib were not included in the International MetastaticRenal Cell Carcinoma Database Consortium (IMDC) prognostic model. SPAZO (NCT02282579) was a nation-wide retrospective observational ...
Leggi tutto

18 Dicembre 2015

International Framework for Cancer Patient Advocacy: Empowering Organizations and Patients to Create a National Call to Action on Cancer

Purpose With the rate of cancer and other noncommunicable diseases (NCDs) growing globally, cancer prevention and control efforts are critical internationally. Moreover, since the 2011 United Nations High-Level Meeting on NCDs, the international health and development community ...
Leggi tutto

18 Dicembre 2015

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain

...
Leggi tutto

18 Dicembre 2015

Global Practice and Efficiency of Multidisciplinary Tumor Boards: Results of an American Society of Clinical Oncology International Survey

Purpose: Multidisciplinary tumor boards (MDTBs) are universally recommended, but recent literature has challenged their efficiency. Methods: The American Society of Clinical Oncology (ASCO) conducted a survey of a randomly selected cohort of international ASCO members. The ...
Leggi tutto

18 Dicembre 2015

16 dicembre 2015 – La FDA approva alectinib per il trattamento del cancro del polmone ALK-positivo

18 Dicembre 2015

14 dicembre 2015 – Influenza: in Italia attività dei virus ancora a livelli base, periodo utile per vaccinazione

18 Dicembre 2015

15 dicembre 2015 – FDA approva trattamento di emergenza per il sovradosaggio di alcuni tipi di chemioterapia

18 Dicembre 2015

Limited screening with versus without 18F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial

Background: Clear guidelines for the investigation of occult malignancy after unprovoked venous thromboembolism are not yet available. 18F-fluorodeoxyglucose (18F-FDG) PET/CT could serve as a comprehensive screening strategy for occult malignancy in this context. We aimed ...
Leggi tutto

18 Dicembre 2015

Is Cancer Pain Control Improved by a Simple WHO Pain Analgesic Ladder Approach Combined With Tumor-Directed Treatment?

The practical use of the WHO analgesic ladder has evolved over time; is there a need for a formal change? Taking into consideration that pain is the symptom most feared by patients and families, and that studies have demonstrated that 90% of patients with cancer experience ...
Leggi tutto